Discovery of Novel Biomarkers for Epstein Barr Virus (EBV) Infection Related Cancers - HL Study (Old ID 23629)
National Institute of Health
Role
Principal Investigator
Description
There is a large body of evidence indicating that Epstein-Barr virus (EBV) actively contributes to the pathogenesis of multiple tumours. We hypothesize that the antibody response to EBV in individuals with and without cancer (cases and controls) using our proprietary EBV proteome array, to identify an antibody signature which predicts cancer risk. The ultimate goal is an immunodiagnostic test to identify individuals in the general population who are at high risk of developing infection-related cancers. Extending previous studies, we will probe defined samples from the HL study provided by colleagues at NIH/NCI.
Date
26 Jul 2017 - 25 Jul 2018
Project Type
CONTRACT_RESEARCH
Keywords
Biomarker discovery
Funding Body
National Institute of Health
Amount
28806
Project Team
N/A